San Fernando Valley Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

SPECIAL REPORT: Healthy Opportunity

Developer checks in to Antelope Valley with hospital-adjacent wellness center.L.A. developer John Thomas proposes a health care oasis in Antelope Valley’s high desert.

By Carol Lawrence February 8, 2016 midnight   $$ Share

Amgen Expands Board

Amgen Inc. on Friday announced that the company has appointed Ellen Kullman to its board of directors, expanding it from 13 to 14 members.

Cancer Firm Akriveia Gets Funding

Biotech company Akriveia Therapeutics has received a $7.5 million Series A investment from an East Coast venture capital firm.

New Exec for Henry Mayo Hospital

Henry Mayo Newhall Hospital in Valencia has named a new chief medical officer and vice president of professional services, the hospital announced Wednesday.

St. Jude Alerts Patients About Pacemaker Batteries

St. Jude Medical Inc. has alerted patients and doctors that some of its implanted heart devices have battery defects that may cause premature power loss.

Valley Assisted Living Homes Sold

Los Angeles real estate brokerage CBRE Inc. has arranged the sale of a $1.15 billion portfolio that includes several Valley health care properties.

ApolloMed Expands to Lompoc

Health management company Apollo Medical Holdings Inc. announced Monday that its affiliate medical group ApolloMed Hospitalists has been contracted to provide its services to Lompoc Valley Medical Center.

Avita Opens Clinic in Tehran

Avita Medical Ltd. is opening a dedicated clinic for its regenerative skin treatments in Iran, the company announced Wednesday.

Lancaster Nurses End One-Day Strike

About 1,000 nurses at Antelope Valley Hospital on Thursday ended their 24-hour strike, which was the first of its kind in the hospital’s 61-year history.

Assisted Living Facility Breaks Ground

An assisted living and memory care facility has received more than $16 million in financing to break ground this month in Thousand Oaks.

MannKind Faces Delisting, Shares Slump

MannKind Corp. on Friday announced that it has received a delisting notice from the Nasdaq stock exchange, as the company has traded below $1 for more than 30 days.

FDA Approves Amgen's Humira Biosimilar

Amgen Inc.’s biosimilar to top-selling drug Humira was approved Friday by the U.S. Food and Drug Administration.

Study Confirms Effectiveness of Amgen Osteoporosis Drug

Amgen Inc. and UCB Inc. have released results from their Phase III FRAME study of osteoporosis medication Romosozumab.

Preview: Regulators Kill a Hit Painkiller

What do you do when one of your hottest-selling products becomes contraband?

Simulations Plus Posts Revenue Gains

Simulations Plus on Monday announced preliminary financial results for its fiscal fourth quarter and full year.

Amgen Buys Myeloma Drug

Amgen Inc. has acquired worldwide development and commercial rights for a phase-1 multiple myeloma drug from German pharmaceutical company Boehringer Ingelheim, the companies announced Thursday.